fda warning letter hims & hers compounded semaglutide september 2025 U.S. sends drug advertising letters to Lilly, Novo, Hims & Hers stock crashes

Michael Murray, we have developed products that enhance overall well-being and demonstrate our dedication to addressing our customers' needs. A growing market According to a recent survey by KFF and reported by CNN, about 6% of American adults, or more than 15 million people, are currently being prescribed GLP-1 drugs like Ozempic or Mounjaro

Understanding the dosage differences between the two helps you make an informed choice about which medication to request from your Peak Wellness provider

Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma

However, they are now seeing competition from other companies manufacturing compounded or non-branded semaglutide, which is bringing the price down

Refer to the approved prescribing information for each specific product for titration guidance

doi:10.1111/j.1530-0277.1991.tb00532.x